Cannabis for seniors: pain, sleep & risks from 65

Cannabis in older people: Growing relevance

People over the age of 65 are the fastest growing group of new patients for medicinal cannabis in Germany. Chronic pain, sleep disorders, appetite problems and neurodegenerative diseases – all common ailments of old age – are also the strongest indications for cannabis therapy. At the same time, this age group is particularly vulnerable to adverse effects.

The endocannabinoid system changes with age: CB1 receptor density decreases (especially in the hippocampus), FAAH activity increases, anandamide levels decrease. This age-typical ECS deficit explains why older patients often respond more strongly to cannabinoids – but also more strongly to side effects.

Most common indications from 65

Specific risks for senior citizens

Risk of falling: the most critical risk in older patients. THC causes balance disorders, hypotension and cognitive impairment – all known fall risk factors. Especially in the first 2-4 hours after THC ingestion, the risk of falling is significantly increased. Starting with very low doses (1-2.5 mg THC) and taking it strictly in the evening (in bed) reduces this risk.

Cardiovascular effect: THC increases heart rate by 20-100 BPM for 3-8 hours via sympathetic activation. With existing CHD, heart failure or atrial fibrillation – all common diseases over 65 – this is a direct risk. CBD has a more favorable cardiovascular effect (slight reduction in HF). For heart patients: cannabis only after cardiologic clearance.

Cognitive impairment: Hippocampal CB1 decline in old age means less cognitive reserve. THC can cause more severe memory and attention disorders in older patients than in younger ones – paradoxically, as THC is often used for dementia symptoms. The rule here is: lowest effective dose.

Polypharmacy and CYP interactions: Elderly patients take an average of 5-8 medications daily. Cannabis affects CYP2C9, CYP3A4 and CYP2D6 – enzymes that break down warfarin, statins, beta-blockers, antidiabetics and many other drugs. Interactions can significantly shift plasma levels of these drugs.

Start-Low-Go-Slow: Dosage for seniors

The standard rule for cannabis beginners applies even more stringently to older patients:

Week 1-2: CBD 5-10 mg daily (in the morning), no THC. Monitoring for drowsiness, orthostatic hypotension, feeling of falling.

Week 3-4: Increase CBD to 25 mg. If insomnia: add 1 mg THC in the evening. Take in bed in the evening – never during the day when actively mobile.

Titration: Increase THC dose by a maximum of 1 mg every 7 days. Target dose for seniors: 2.5-10 mg THC (significantly lower than for younger people).

Form of application: oil (sublingual) or capsules – no smoking, no vaporizer (respiratory impairment), no edibles (uncontrollable dosage risky for seniors).

Interaction check for typical senior medications

– Warfarin/phenprocoumon: CBD inhibits CYP2C9 → INR increases → increased risk of bleeding. Close INR monitoring is mandatory.
– Statins (simvastatin, atorvastatin): CYP3A4 inhibition by CBD → increased statin levels → risk of myopathy. Close CK monitoring.
– Antidiabetics (sulfonylureas): CYP2C9 inhibition → prolonged duration of action → risk of hypoglycemia. Intensify BG monitoring.
– Antihypertensives: Additive blood pressure reduction (CBD + THC) → hypotension, fall. Blood pressure self-monitoring.

Medical cannabis in the care sector

Cannabis therapy is becoming increasingly important in care facilities. The advantages over traditional alternatives (opioids, benzodiazepines, antipsychotics) are considerable:
– No risk of respiratory depression (as with opioids)
– No dependency potential as with benzodiazepines
– No increased risk of stroke (as with antipsychotics for dementia)

The challenge lies in individual dose determination and CYP monitoring in polypharmacy.

FAQ: Cannabis for older people

Summary

Elderly patients over 65 are a growing cannabis target group with a special risk-opportunity profile: high indication density (pain, sleep, dementia), but increased vulnerability to falls, cardiovascular side effects and polypharmacy interactions. Start-Low-Go-Slow is not optional for seniors, but mandatory. CBD-first, THC in the lowest effective doses (1-5 mg), taken in the evening, no smoking. SHI reimbursement is also possible for seniors for recognized indications.